Abiopharma

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART Systems Convertible Dual Lumen Cannula Device and Method of Use

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

Ginkgo Bioworks - Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

Curis Provides Updated Data from its Frontline AML Triplet Study

Teva Pharmaceutical Industries Ltd. - Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-749) for the Once-Monthly Treatment of Schizophrenia in Adults

Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism

Natera - Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting

Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates

CoyaTherapeutics - Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS